Polyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectives
- 31 October 1991
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 17 (2), 187-198
- https://doi.org/10.1016/0168-3659(91)90058-l
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticlesCancer Chemotherapy and Pharmacology, 1990
- Increased eytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodaroneBiomaterials, 1989
- The use of poly (isobutyl cyanoacrylate) nanoparticles with selected antifungal drugsFEMS Microbiology Letters, 1987
- Unloaded polyisobutylcyanoacrylate nanoparticles: efficiency against bloodstream trypanosomesJournal of Pharmacy and Pharmacology, 1987
- The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer - poloxamine 908Life Sciences, 1987
- Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodiesNature, 1985
- Degradation of poly (isobutyl cyanoacrylate) nanoparticlesBiomaterials, 1984
- The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338)FEBS Letters, 1984
- Actinomycin D adsorbed on polymethylcyanoacrylate nanoparticles: Increased efficiency against an experimental tumorEuropean Journal of Cancer (1965), 1980
- Nanocapsules: A new type of lysosomotropic carrierFEBS Letters, 1977